Drugs / DNA vaccine
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04049864 | Jan 2019 → Dec 2023 | neuroblastoma | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | Unknown | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT01498718 | Dec 2011 → Apr 2013 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00988767 | Feb 2001 → Nov 2003 | chronic hepatitis B virus infection | French National Institute of Health and Medical Research | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00870987 | May 2009 → Apr 2014 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01498718 ↗ |
| Modality | Vaccine | “DNA vaccine prime” NCT00870987 ↗ |
| Route | Intramuscular | “intramuscular injections” NCT00988767 ↗ |